Oppenheimer Sees 'Favorable Setup' in Biogen (BIIB) on Alzheimer's Dynamics

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. ABBV
4. CL
5. TFII
6. LYB
7. LITE
8. NVT
9. SPY
10. AAPL

Go back to Oppenheimer Sees 'Favorable Setup' in Biogen (BIIB) on Alzheimer's Dynamics

Guggenheim Upgrades Biogen (BIIB) to Buy

May 1, 2023 6:10 AM EDT

Guggenheim analyst Yatin Suneja upgraded Biogen (NASDAQ: BIIB) from Neutral to Buy with a price target of $350.00 (from $270.00).


For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.


Shares of Biogen closed at $304.23 yesterday.

... More